Global X S&P Biotech ETF (CURE) Review & Analysis
- +0.2% in September (total return), ahead of the median international shares ETF at +0.0%.
- The unit price closed the month at $77.55, 5% below its 12-month high (range $46.01 to $81.49).
About CURE
CURE is an international shares ETF from Global X, listed on the ASX since November 2018. With $50m under management it is number 169 of 254 international shares ETFs by size. The management fee is 0.45% a year, about $45 on every $10,000 invested, cheaper than the typical international shares ETF at 0.55%.
Its largest holdings are Moderna Inc, Twist Bioscience Corp and Natera Inc, and the top 10 make up 18% of the fund. By sector it leans towards health care (100%).
Over five years it has returned +5.2% a year including distributions, against +8.8% for the median international shares ETF. With its focus on healthcare, it is the kind of fund many investors use as a smaller satellite holding alongside a diversified core.
CURE distributions and dividend dates
CURE pays distributions yearly, usually going ex-distribution in June, with payment about 15 days after the ex-date. (Pattern estimated from recent payments.)
The latest distribution was $0.024 per unit (0% franked), ex-distribution on 30 June 2022 and paid on 15 July 2022. To receive it you need to own CURE before the ex-date.
Its distribution yield over the past 12 months is about 0.0%. Distributions vary and past payments are not a guide to future ones.
From ASX announcements, updated nightly. See every ETF in the dividend calendar.
Compare CURE with
| Fee | 0.45% | 0.04% |
| 1 year | +50.9% | +10.1% |
| 5 yrs p.a. | +5.2% | +13.4% |
| Size | $50m | $14.9bn |
| Fee | 0.45% | 0.10% |
| 1 year | +50.9% | +15.4% |
| 5 yrs p.a. | +5.2% | +10.9% |
| Size | $50m | $4.3bn |
| Fee | 0.45% | 0.29% |
| 1 year | +50.9% | +6.6% |
| 5 yrs p.a. | +5.2% | +7.9% |
| Size | $50m | $1.4bn |
| Fee | 0.45% | 0.07% |
| 1 year | +50.9% | +7.6% |
| 5 yrs p.a. | +5.2% | +9.3% |
| Size | $50m | $858m |
CURE price by TradingView
| Stock Code | CURE |
|---|---|
| Fund Manager | Global X |
| Asset Class | International shares |
| AUM | $50m |
| MER (%) | 0.45% |
| Net flows (Sep) | $0.0m |
| Last Price | $77.55 |
| 52-Week Range | $46.01 – $81.49 |
| Bid/Ask Spread | 0.34% |
| Listing Date | 12/11/2018 |
| Exchange | ASX |
| Index | Not yet in our data. See the PDS |
| Issuer website | Global X ↗ |
Performance (% return)
$10,000 invested…
Value at 30 September 2026 with distributions reinvested, before tax and brokerage.
Total returns including distributions, to 30 September 2026. 1M, 1Y, 3Y and 5Y bars are cumulative.